Jorik H Amesz
Overview
Explore the profile of Jorik H Amesz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Amesz J, Langmuur S, Zhang L, Manintveld O, Schinkel A, de Jong P, et al.
Biomed Pharmacother
. 2023 Dec;
170:116036.
PMID: 38134635
Hypertrophic cardiomyopathy (HCM) is the most common inherited myocardial disorder of the heart, but effective treatment options remain limited. Mavacamten, a direct myosin modulator, has been presented as novel pharmacological...
12.
Kharbanda R, Ramdat Misier N, van Schie M, Zwijnenburg R, Amesz J, Knops P, et al.
JACC Clin Electrophysiol
. 2023 Jul;
9(9):1843-1853.
PMID: 37480858
Background: Low-level vagus nerve stimulation through the tragus (tLLVNS) is increasingly acknowledged as a therapeutic strategy to prevent and treat atrial fibrillation. However, a lack in understanding of the exact...
13.
Amesz J, de Groot N, Langmuur S, Azzouzi H, Tiggeloven V, van Rooij M, et al.
Sci Rep
. 2023 Mar;
13(1):3648.
PMID: 36871094
Living myocardial slices (LMS) are beating sections of intact human myocardium that maintain 3D microarchitecture and multicellularity, thereby overcoming most limitations of conventional myocardial cell cultures. We introduce a novel...
14.
Bierhuizen M, Amesz J, de Groot N, Taverne Y
Front Physiol
. 2023 Feb;
14:1130674.
PMID: 36846319
No abstract available.
15.
Amesz J, Langmuur S, Epskamp N, Bogers A, de Groot N, Manintveld O, et al.
Cardiovasc Drugs Ther
. 2023 Feb;
38(4):659-666.
PMID: 36780068
Purpose: Multiple randomized controlled trials have presented SGLT2 inhibitors (SGLT2i) as novel pharmacological therapy for patients with heart failure, resulting in reductions in hospitalization for heart failure and mortality. Given...
16.
Amesz J, Zhang L, Everts B, de Groot N, Taverne Y
Front Physiol
. 2023 Jan;
14:1076261.
PMID: 36711023
Living myocardial slices (LMS) are ultrathin (150-400 µm) sections of intact myocardium that can be used as a comprehensive model for cardiac arrhythmia research. The recent introduction of biomimetic electromechanical...
17.
Amesz J, Langmuur S, van Schie M, Taverne Y
JTCVS Tech
. 2022 Jun;
13:128-130.
PMID: 35711226
No abstract available.
18.
Langmuur S, Amesz J, Veen K, Bogers A, Manintveld O, Taverne Y
Transplantation
. 2022 May;
106(9):1745-1753.
PMID: 35618669
Background: Heart transplantation (HTx) is, at present, the most effective therapy for end-stage heart failure patients; however, the number of patients on the waiting list is rising globally, further increasing...
19.
Amesz J, Roest S, Taverne Y, Manintveld O
J Am Coll Cardiol
. 2022 Apr;
79(17):e423.
PMID: 35483763
No abstract available.